Published on March 21, 2007
Exhibit
32.1
CERTIFICATION
PURSUANT TO
SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
In
connection with the Annual Report on Form 10-KSB of Novelos
Therapeutics, Inc. (the “Company”) for the year ended December 31, 2006, as
filed with the Securities and Exchange Commission on the date hereof (the
“Report”), I, Harry S. Palmin, Chief Executive Officer and President of the
Company, and I, George R. Vaughn, Chief Financial Officer of the Company,
certify, to the best of our knowledge and belief, pursuant to 18
U.S.C.§ 1350, adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002,
that:
| 1) |
the
Report fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934, as amended;
and
|
| 2) |
the
information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the
Company.
|
|
/s/
HARRY S. PALMIN
|
/s/
GEORGE R. VAUGHN
|
|||
|
Harry
S. Palmin
|
George
R. Vaughn
|
|||
|
Chief
Executive Officer and President
|
Chief
Financial Officer
|
|||
Dated:
March 21, 2007
A
signed
original of this written statement required by Section 906, or other
document authenticating, acknowledging, or otherwise adopting the signature
that
appears in typed form within the electronic version of this written statement
required by Section 906, has been provided to Novelos
Therapeutics, Inc. and will be retained by Novelos Therapeutics, Inc.
and furnished to the Securities and Exchange Commission or its staff upon
request.